ALLMedicine™ Pituitary Macroadenomas Center
Research & Reviews 118 results
https://doi.org/10.1016/j.wneu.2021.07.022
World Neurosurgery; Jamaluddin MA, Patel BK et. al.
Jul 23rd, 2021 - Pituitary macroadenomas, occasionally, disrupt the sellar diaphragm and extend directly to the third ventricle causing hydrocephalus. We present the results of a single stage extended endoscopic approach for managing giant pituitary adenomas occup...
https://doi.org/10.1016/j.jocn.2021.05.058
Journal of Clinical Neuroscience : Official Journal of Th... Akkaya E, Akgun MY et. al.
Jul 20th, 2021 - Any preoperative diagnostic assessment that can predict the success of the operation in acromegaly will provide a positive impact on overall remission rates. The aim of this study is to reveal whether the signal intensity in T2-weighted Magnetic R...
https://doi.org/10.1097/ACO.0000000000001035
Current Opinion in Anaesthesiology; Esfahani K, Dunn LK
Jul 17th, 2021 - Pituitary adenoma resections comprise a large proportion of intracranial tumor surgeries. This patient population is medically and physiologically complex and requires careful perioperative planning and management on the part of the anesthesiologi...
https://doi.org/10.1080/02688697.2021.1950629
British Journal of Neurosurgery; Mortini P, Albano L et. al.
Jul 17th, 2021 - To analyse the efficacy and safety of the transsphenoidal microsurgical approach with open sella technique (OST) for the treatment of pituitary adenoma (PA) with suprasellar extension. We retrospectively reviewed 2305 consecutive patients with PA ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8194144
BMC Endocrine Disorders; Seejore K, Alavi SA et. al.
Jun 12th, 2021 - Transsphenoidal surgery (TSS) remains the treatment of choice for non-functioning pituitary macroadenomas (NFPMA). The value of measuring tumour volumes before and after surgery, and its influence on endocrine outcomes and further treatment of the...
Clinicaltrials.gov 3 results
https://clinicaltrials.gov/ct2/show/NCT01444209
May 2nd, 2018 - This study is a single arm Phase II pilot trial. Patients enrolled on the trial will undergo implantation of high activity iodine-125 seeds into their pituitary adenoma. The tumor response to treatment will be monitored as well as change in visual...
https://clinicaltrials.gov/ct2/show/NCT03363126
Dec 6th, 2017 - Endoscopic endonasal transsphenoidal surgery is a procedure for the treatment of pituitary macroadenomas that cause visual impairment through optic chiasm compression. The aim of this retrospective study is to describe visual outcome after this pr...
https://clinicaltrials.gov/ct2/show/NCT01371643
Aug 29th, 2016 - The current goal of treatment for people with acromegaly is normalization of both growth hormone (GH) and insulin-like-growth-factor-1 (IGF-1) levels. Normalization of GH and IGF-1 levels attenuates the morbidity (hypertension, cardiovascular dise...
